The Global Cardiovascular Genetic Testing Market, valued at approximately USD 9.07 billion in 2023, is projected to grow at a robust compound annual growth rate (CAGR) of 11.2% du ...

Precision Medicine Online and My Gene Counsel have partnered since 2019 on the "Genetic Testing Challenges" series to highlight real-world issues medical professionals are encountering as genetic ...

JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Objectives Current evidence recommend Microarray testing as first-tier investigation for Children with developmental Delay and moderate to severe intellectual disability. Our aim is to see the ...

Abstract: The paper describes a novel approach to the microarray image simulation in order to provide researchers with a tool for testing and evaluating the performance of analysis software.

A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children. This shift could enable earlier diagnoses for families and save ...